Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Mannkind’s inhaled insulin Afrezza edges closer to market

August 19, 2013 Research and Development, Sales and Marketing Afrezza, Exubera, Mannkind, inhaled insulin

News

Algeta appoints Dr Andreas Menrad as chief scientific officer

August 19, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algeta, Genzyme, Sanofi

Appointment

Former British Airways head becomes NHSBSA chair

August 19, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Airwayss, NHS Business Services Authority, Silla Maizey

Appointment

New drug pricing plans will ‘damage UK biotech’

August 16, 2013 Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech

The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
News

Boehringer to shut down Petersburg chemicals facility

August 16, 2013 Manufacturing and Production, Sales and Marketing Boehringer, Petersburg

Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …
News

Price cut not enough for Pfizer’s Xalkori

August 16, 2013 Sales and Marketing NICE, Pfizer, Xalkori, lung cancer

In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …
News

GSK and Roche get EU breast cancer indication

August 15, 2013 Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …
News

Celgene’s multiple myeloma pill launched in UK

August 15, 2013 Sales and Marketing Celgene, Velcade, low, myeloma

Celgene’s new oral blood cancer drug pomalidomide has been launched in the UK and Ireland as a third line treatment …
News

ABPI publishes trial disclosure ‘toolkit’

August 15, 2013 Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency

The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements.  The …
News

Astellas hires senior VP from rival Takeda

August 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
Appointment

HIV pill Tivicay gains FDA approval

August 14, 2013 Sales and Marketing FDA, GSK, Tivicay, ViiV

ViiV and partner GlaxoSmithKline’s new HIV drug Tivicay has been shown the FDA’s green light for distribution in the US. …
News

Phoenix from the flames for Lilly cancer drug

August 14, 2013 Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …
News

New president and chief executive for EMMES

August 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES

Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …
Appointment

The new NHS: a marriage of inconvenience?

August 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house

As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …
Feature

Vical melanoma drug dropped

August 13, 2013 Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026